MedPath

CENTRE GEORGES FRANCOIS LECLERC

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Predictive Study of Radiation Induced Sarcoma

Not Applicable
Completed
Conditions
Radiation Induced Sarcoma
Interventions
Genetic: tumor genetic predisposition to develop sarcoma assessment
First Posted Date
2012-01-05
Last Posted Date
2017-06-12
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
360
Registration Number
NCT01504360
Locations
🇫🇷

CGFL, Dijon, France

Spectro-IRM and Evaluation Response to Prostatic Radiotherapy

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Other: MR-Spectroscopy
First Posted Date
2011-08-09
Last Posted Date
2017-06-21
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
90
Registration Number
NCT01412853
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, France

Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas

Early Phase 1
Terminated
Conditions
Non-small Cell Lung Cancer Metastatic
Interventions
Biological: CTC
First Posted Date
2011-06-27
Last Posted Date
2020-01-27
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
30
Registration Number
NCT01380795
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, France

Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus

Phase 2
Completed
Conditions
Esophageal Cancer
Interventions
Radiation: Conformal 3D Radiotherapy with " ENI "-type prophylactic irradiation of the lymph node
Radiation: Boost
First Posted Date
2011-05-05
Last Posted Date
2020-01-27
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
196
Registration Number
NCT01348217
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, France

Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure

Phase 2
Completed
Conditions
Colorectal Cancer
Liver Metastases
Interventions
Drug: oxaliplatin
Drug: other intravenous chemotherapy drugs
Drug: raltitrexed
First Posted Date
2011-05-05
Last Posted Date
2018-07-16
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
31
Registration Number
NCT01348412
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, France

Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy

Conditions
Head and Neck Cancer
First Posted Date
2010-09-29
Last Posted Date
2013-08-07
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
200
Registration Number
NCT01210872
Locations
🇫🇷

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France

Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer

Phase 1
Completed
Conditions
Metastatic Breast Cancer
Interventions
First Posted Date
2010-01-08
Last Posted Date
2012-09-25
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
17
Registration Number
NCT01044485
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, Bourgogne, France

Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults

Phase 1
Completed
Conditions
Glioblastoma
Interventions
Radiation: radiotherapy
Drug: temozolomide
First Posted Date
2010-01-06
Last Posted Date
2012-09-25
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
10
Registration Number
NCT01043536
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, Bourgogne, France

Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma

Phase 2
Completed
Conditions
Naive Unresectable Glioblastoma
Interventions
First Posted Date
2009-12-01
Last Posted Date
2012-09-25
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
134
Registration Number
NCT01022918
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, Bourgogne, France

© Copyright 2025. All Rights Reserved by MedPath